Mitria Medical Partners with T45 Labs to Advance Novel Mitral Valve Repair Therapy

PartnershipSubvalvular SpacerPositive

AI Analysis

Summary

Mitria Medical, founded at Cleveland Clinic, announced a partnership with T45 Labs to advance its investigational Subvalvular Spacer therapy for functional mitral regurgitation. The company appointed Marwan Berrada-Sounni as CEO to lead the therapy into its next phase of clinical evaluation.

Importance:6/10

Sentiment:

0.60

partnershipmitral valve repairclinical developmentfunctional mitral regurgitationleadership

Related Companies

$MEHA $MDCE

Read the original article

Published by PR Newswire Clinical Trials on September 29, 2026 1:02 PM

Read Original